Feasibility study of personalized peptide vaccination for metastatic recurrent triple-negative breast cancer patients

INTRODUCTION: Since treatment modalities for metastatic recurrent triple-negative breast cancer (mrTNBC) are limited, a novel treatment approach including immunotherapy is required. We have developed a novel regimen of personalized peptide vaccination (PPV), in which vaccine antigens are individuall...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Breast Cancer Res
Main Authors: Takahashi, Ryuji, Toh, Uhi, Iwakuma, Nobutaka, Takenaka, Miki, Otsuka, Hiroko, Furukawa, Mina, Fujii, Teruhiko, Seki, Naoko, Kawahara, Akihiko, Kage, Masayoshi, Matsueda, Satoko, Akagi, Yoshito, Yamada, Akira, Itoh, Kyogo, Sasada, Tetsuro
פורמט: Artigo
שפה:Inglês
יצא לאור: BioMed Central 2014
נושאים:
Research Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC4227005/
https://ncbi.nlm.nih.gov/pubmed/24992895
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/bcr3685
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים